"Aminophenols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Phenols substituted in any position by an amino group.
Descriptor ID |
D000627
|
MeSH Number(s) |
D02.092.146.100 D02.455.426.559.389.657.050
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminophenols".
Below are MeSH descriptors whose meaning is more specific than "Aminophenols".
This graph shows the total number of publications written about "Aminophenols" by people in this website by year, and whether "Aminophenols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminophenols" by people in Profiles.
-
Papilledema and hypervitaminosis A after elexacaftor/tezacaftor/ivacaftor for cystic fibrosis. Can J Ophthalmol. 2022 02; 57(1):e6-e10.
-
A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation. J Cyst Fibros. 2021 03; 20(2):234-242.
-
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients. J Cyst Fibros. 2021 03; 20(2):333-338.
-
A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy. Cell Death Dis. 2018 07 13; 9(7):780.
-
Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR. J Cyst Fibros. 2018 03; 17(2):228-235.
-
Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor. Pediatrics. 2017 Feb; 139(2).
-
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros. 2014 Dec; 13(6):674-80.
-
LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron. 2007 Mar 01; 53(5):703-17.
-
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity. Cancer Res. 2005 Mar 01; 65(5):1961-72.
-
The oxidation of p-phenetidine by horseradish peroxidase and prostaglandin synthase and the fate of glutathione during such oxidations. Biochem Pharmacol. 1985 Feb 01; 34(3):343-51.